跳至主要内容
临床试验/NCT02545881
NCT02545881Unknown不适用

Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2015年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Histological prostate cancer aggressiveness (Gleason grade)

研究概览

简要总结

The purpose of this study is to develop, validate, and evaluate the correlation of novel magnetic resonance imaging (MRI) methods with prostate cancer aggressiveness and histological data obtained during prostatectomy.

详细描述

Prostate cancer is one of the most common neoplastic diseases in men. Prostate specific antigen (PSA) has only a limited role in the diagnosis and characterization of prostate cancer. The diagnosis of prostate cancer is still most commonly done by transrectal ultrasonography (TRUS) guided biopsy. However, TRUS guided biopsy carries a risk of increase in complications. There is an increasing interest in developing more accurate non-invasive imaging modalities which could potentially detect prostate cancer aggressiveness.

Diffusion weighted imaging (DWI) and rotating frame relaxation measurements have shown to be particularly promising in prostate cancer detection and characterization. This study which focuses on further development and validation of DWI and rotating frame relaxation measurements will enroll 200 men with histologically diagnosed prostate cancer who will undergo magnetic resonance imaging (MRI) before prostatectomy. Anatomical MRI and novel acquisition methods focusing on DWI and rotating frame relaxation measurements will be performed using surface coils to non-invasively detect and characterize prostate cancer.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
30 Years 至 85 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age: 35 to 85 years
  • Language spoken: Finnish
  • Performance status: Karnofsky score 70 or better or WHO performance status 2 or better
  • Diagnosis: Histologically confirmed adenocarcinoma of prostate
  • No previous surgical, radiation or endocrine treatment for prostate carcinoma
  • Clinical stage T1c-T3aN0 based on transrectal ultrasound, pelvic CT and bone scintigraphy
  • Time period between the last biopsy and scheduled radical prostatectomy less than 8 months
  • Mental status: Patients must be able to understand the meaning of the study
  • Informed consent: The patient must sign the appropriate Ethics Committee (EC) approved informed consent documents in the presence of the designated staff

排除标准

  • previous prostate surgeries, e.g. TURP (transurethral prostatic resection)
  • symptomatic acute prostatitis
  • contraindications for MRI (cardiac pacemaker, intracranial clips etc)
  • uncontrolled serious infection
  • claustrophobia

结局指标

主要结局

Histological prostate cancer aggressiveness (Gleason grade)

时间窗: Within 1 month after MR imaging of the prostate

Aim is to study the correlation between MRI parameters (MR relaxation values and different DWI parameters) and histological data including Gleason grade of prostate cancer

MR relaxation values

时间窗: Within 1 month prior to prostatectomy

Aim is to study the correlation between MRI parameters (MR relaxation values and different DWI parameters) and histological data including Gleason grade of prostate cancer

MR DWI parameters

时间窗: Within 1 month prior to prostatectomy

Aim is to study the correlation between MRI parameters (MR relaxation values and different DWI parameters) and histological data including Gleason grade of prostate cancer

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hannu Aronen

Professor, Chief Physician

Turku University Hospital

研究点 (1)

Loading locations...

相似试验